Hematopoietic, immunomodulatory and epithelial effects of interleukin-11

Leukemia

Volumn 13, Issue 9, 1999, Pages 1307-1315

  Schwertschlag, U S ^a   Trepicchio, W L ^a   Dykstra, K H ^a   Keith, J C ^a   Turner, K J ^a   Dorner, A J ^a  

^a PFIZER INC   (United States)

Author keywords

rhIL 11

Indexed keywords

ACUTE PHASE PROTEIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; CYTOCHROME P450 REDUCTASE; CYTOKINE; FERRITIN; FIBRINOGEN; GAMMA INTERFERON; GROWTH FACTOR; HAPTOGLOBIN; HEME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; OXIDOREDUCTASE; RECOMBINANT INTERLEUKIN 11; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE PRODUCTION; ENZYME INDUCTION; ESCHERICHIA COLI; HEMATOPOIETIC CELL; HEMODILUTION; HUMAN; IMMUNOMODULATION; INFLAMMATION; INTESTINE EPITHELIUM; LEUKEMIA; MACROPHAGE; MEGAKARYOCYTE; PRIORITY JOURNAL; PSORIASIS; RECOMBINANT DNA TECHNOLOGY; REVIEW; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SODIUM EXCRETION; STEM CELL; T LYMPHOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0032823806     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401514     Document Type: Review

References (98)

1. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM Jr, Leary AC, Sibley B, Clark SC, Williams DA, Yang Y-C. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990; 87: 7512-7516.
2. Paul SR, Schendel P. The cloning and biological characterization of recombinant human interleukin-11. Int J Cell Cloning 1992; 10: 135-143.
3. Taga T. The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines. Ann Med 1997; 29: 63-72.
4. Davidson AJ, Freeman S-A, Crosier KE, Wood CR, Crosier PS. Expression of murine interleukin 11 and its receptor alpha-chain in adult and embryonic tissues. Stem Cells 1997; 15: 119-124.
5. Hilton DJ, Hilton AA, Raicevic A, Rakar S, Harrison-Smith M, Gough NM, Begley CG, Metcalf D, Nicola NA, Willson TA. Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J 1994; 13: 4765-4775.
6. Wang JC, Chen C, Lou L-H, Mora M. Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia. Leukemia 1997; 11: 1827-1832.
7. Branisteanu I, Pijnenborg R, Spiessens C, Van der Auwera I, Keith JC Jr, Van Assche FA. Detection of immunoreactive interleukin-11 in human follicular fluid: correlations with ovarian steroid, insulin-like growth factor I levels, and follicular maturity. Fertil Steril 1997; 67: 1054-1058.
8. Chang M, Williams A, Ishizawa L, Knoppel A, Van de Ven C, Cairo MS. Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats. Blood Cells Mol Dis 1996; 22: 57-67.
9. Schendel P, Turner K. Interleukin-11. In: Cytokines. Academic Press, 1998, pp 169-182.
10. Dorner AJ, Goldman SJ, Keith JC Jr. Interleukin-11: biological activity and clinical studies. BioDrugs 1997; 8: 418-429.
11. McKinley D, Wu Q, Yang-Feng T, Yang Y-C. Genomic sequence and chromosomal location of human interleukin-11 (IL11). Genomics 1992; 13: 814-819.
12. Bitko V, Velazquez A, Yang L, Yang YC, Barik S. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-κB and is inhibited by sodium salicylate and aspirin. Virology 1997; 232: 369-378.
13. Czupryn MJ, McCoy JM, Scoble HA. Structure-function relationships in human interleukin-11: identification of regions involved in activity by chemical modification and site-directed mutagenesis. J Biol Chem 1995; 270: 978-985.
14. Czupryn M, Bennett F, Dube J, Grant K, Scoble H, Sookdeo H, McCoy JM. Alanine-scanning mutagenesis of human interleukin-11: identification of regions important for biological activity. Ann NY Acad Sci 1995; 762: 152-164.
15. Du X, Everett ET, Wnat C, Lee W-H, Yang Z, Williams DA. Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis. J Cell Physiol 1996; 168: 362-372.
16. Neuhaus H, Bettenhausen B, Bilinski P, Simon-Chazottes D, Guenet J-L, Gossler A. Etl2, a novel putative type-I cytokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential. Dev Biol 1994; 166: 531-542.
17. Van Leuven F, Stas L, Hilliker C, Miyake Y, Bilinski P, Gossler A. Molecular cloning and characterization of the human interleukin-11 receptor alpha-chain gene, IL11RA, located on chromosome 9p13. Genomics 1996; 31: 65-70.
18. Bilinski P, Hall MA, Neuhaus H, Gissel C, Heath JK, Gossler A. Two differentially expressed interleukin-11 receptor genes in the mouse genome. Biochem J 1996; 320: 359-363.
19. Robb L, Hilton DJ, Brook-Carter PT, Begley CG. Identification of a second murine interleukin-11 receptor alpha-chain gene (IL11Ra2) with a restricted pattern of expression. Genomics 1997; 40: 387-394.
20. Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med 1996; 183: 2581-2591.
21. Trepicchio WL, Wang L, Bozza M, Dorner AJ. IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J Immunol 1997; 159: 5661-5670.
22. Nandurkar HH, Robb L, Nicholl JK, Hilton DJ, Sutherland GR, Begley CG. The gene for the human interleukin-11 receptor alpha chain locus is highly homologous to the murine gene and contains alternatively spliced first exons. Int J Biochem Cell Biol 1997; 29: 753-766.
23. Cherel M, Sorel M, Apiou F, Lebeau B, Dubois S, Jacques Y, Minvielle S. The human interleukin-11 receptor alpha gene (IL11RA): genomic organization and chromosome mapping. Genomics 1996; 32: 49-53.
24. Cherel M, Sorel M, Lebeau B, Dubois S, Moreau JF, Bataille R, Minvielle S, Jacques Y. Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 1995; 86: 2534-2540.
25. Robb L, Hilton D, Willson T, Begley C. Structural analysis of the gene encoding the murine interleukin-11 receptor alpha chain and alpha related locus. J Biol Chem 1996; 271: 13754-13761.
26. Neddermann P, Graziani R, Ciliberto G, Paonessa G. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro IL-11 receptor complexes with gp130. J Biol Chem 1996; 271: 30986-30991.
27. Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N, Begley CG. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Oncogene 1996; 12: 585-593.
28. Nandurkar HH, Robb L, Tarlinton D, Barnett L, Kontgen F, Begley CG. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood 1997; 90: 2148-2159.
29. Bilinski P, Roopenian D, Gossler A. Maternal IL-11Rα function is required for normal decidua and fetoplacental development in mice. Genes Dev 1998; 12: 2234-2243.
30. Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nature Med 1998; 4: 303-308.
31. Elias JA, Zheng T, Einarsson O, Landry M, Trow T, Rebert N, Panuska J. Epithelial interleukin-11: regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem 1994; 269: 22261-22268.
32. Einarsson O, Geba P, Zhu Z, Landry M, Elias JA. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996; 97: 915-924.
33. Elias JA, Zheng T, Whiting NL, Trow TK, Merrill WW, Zitnik R, Ray P, Alderman EM. IL-1 and transforming growth factor-β regulation of fibroblast-derived IL-11. J Immunol 1994; 152: 2421-2429.
34. Zheng T, Nathanson MH, Elias JA. Histamine augments cytokine-stimulated IL-11 production by human lung fibroblasts. J Immunol 1994; 153: 4742-4752.
35. Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 1993; 268: 21527-21532.
36. Suen Y, Chang M, Lee SM, Buzby JS, Cairo MS. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 1994; 84: 4125-4134.
37. Elias JA, Tang W, Horowitz MC. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 1995; 136: 489-498.
38. Chang M, Suen Y, Meng G, Buzby JS, Bussel J, Shen V, Van DVC, Cairo MS. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood 1996; 88: 3354-3362.
39. Gabay C, Singwe M, Genin B, Meyer O, Mentha G, Le CC, Vischer T, Guerne P-A. Circulating levels of IL-11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase protein by the liver. Clin Exp Immunol 1996; 105: 260-265.
40. Musashi M, Clark SC, Sudo T, Urdal DL, Ogawa M. Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood 1991; 78: 1448-1451.
41. Tsuji K, Lyman SD, Sudo T, Clark SC, Ogawa M. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 1992; 79: 2855-2860.
42. Weich NS, Wang A, Fitzgerald M, Neben TY, Donaldson D, Giannotti J, Yetz-Aldape J, Leven RM, Turner KJ. Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. Blood 1997; 90: 3893-3902.
43. Quesniaux VFJ, Clark SC, Turner K, Fagg B. Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood 1992; 80: 1218-1223.
44. Yin T, Schendel P, Yang Y-C. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin-11. J Exp Med 1992; 175: 211-216.
45. Schlerman FJ, Bree AG, Kaviani M, Nagle SL, Donnelly LH, Mason LE, Schaub RG, Grupp SA, Goldman SJ. Thrombopoietic activity of recombinant human interleukin-11 (rhlL-11) in normal and myelosuppressed nonhuman primates. Stem Cells 1996; 14: 517-532.
46. Bree A, Schlerman F, Timony G, McCarthy K, Stoudemire J. Pharmacokinetics and thrombopoietic effects of recombinant human interleukin-11 (rhlL-11) in nonhuman primates and rodents. Blood 1991; 78 (Suppl. 1): 132a (Abstr.).
47. Neben TY, Loebelenz J, Hayes L, McCarthy K, Stoudemire J, Schaub R, Goldman SJ. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 1993; 81: 901-908.
48. Goldman SJ. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells 1995; 13: 462-471.
49. Leonard JP, Quinto CM, Kozitza MK, Neben TY, Goldman SJ. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 1994, 83: 1499-1506.
50. Hitz SL, Kaviani MD, Schlerman FJ, Bree AG, Grupp SA, Goldman SJ. The hematologic effects of recombinant human interleukin 11 in a myelosuppressed nonhuman primate model. Blood 1995; 86 (Suppl. 1): 898a (Abstr.).
51. Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewy J, Loesch D, Breeden E, Hoffman R, Beach KJ, Kuca B, Kaye J, Sledge GW. A phase I trial of recombinant human interleukin-11 (Neumega rhlL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996; 87: 3615-3624.
52. Tepler I, Elias L, Smith JW II, Hussein M, Rosen G, Chang AY-C, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996; 87: 3607-3614.
53. Schwerkoske J, Schwartzberg L, Weaver CH, Schwertschlag US, Goodfellow J, Bedrosian CL. Phase 1 rhlL-11 auto-BMT Mucositis Group. A phase 1 double-masked, placebo-controlled study to evaluate tolerability of Neumega (rhil-11; oprelvekin) to reduce mucositis in patients with solid tumors or lymphoma receiving high-dose chemotherapy (ct) with autologous peripheral blood stem cell reinfusion. Proc Am Soc Clin Oncol 1999; 18: 584a (Abstr.).
54. Dykstra KH, Loewy J, Schwertschlag U, Kaye JA. A mathematical model of the kinetics of platelet production after high-dose chemotherapy and treatment with Neumega (rhlL-11). Blood 1997; 90: 184b.
55. Booth C, Potten CS. Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 1995; 28: 581-594.
56. Peterson RL, Bozza MM, Dorner AJ. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol 1996; 149: 895-902.
57. Du XX, Doerschuk CM, Orazi A, Williams DA. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 1994; 83: 33-37.
58. Orazi A, Du Z, Yang Z, Kashai M, Williams DA. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 1996; 75: 33-42.
59. Sonis S, Muska A, O'Brien J, Van Vugt A, Langer-Safer P, Keith J. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur J Cancer B Oral Oncol 1995; 31b: 261-266.
60. Sonis ST, Van Vugt AG, McDonald J, Dotoli E, Schwertschlag U, Szklut P, Keith J. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters. Cytokine 1997; 9: 605-612.
61. Du X, Liu Q, Yang Z, Orazi A, Rescorla FJ, Grosfeld JL, Williams DA. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am J Physiol 1997; 272: 545-552.
62. Fiore NF, Ledniczky G, Liu Q, Orazi A, Du X, Williams DA, Grosfeld JL. Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection. J Pediatr Surg 1998; 33: 24-29.
63. Liu Q, Du XX, Schindel DT, Yang ZX, Rescorla FJ, Williams DA, Grosfeld JL, Smith S, Hendren WH, Guzzetta PC, Bruch SW. Trophic effects of interleukin-11 in rats with experimental short bowel syndrome. J Pediatr Surg 1996; 31: 1047-1051.
64. Baumann H, Schendel P. Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 1991; 266: 20424-20427.
65. Roeb E, Graeve L, Hoffman R, Decker K, Edwards DR, Heinrich PC. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 1993; 18: 1437-1442.
66. Fukuda Y, Sassa S. Effect of interleukin-11 on the levels of mRNAs encoding heme oxygenase and haptoglobin in human HEPG2 hepatoma cells. Biochem Biophys Res Commun 1993; 193: 297-302.
67. Kaye JA, Loewy J, Blume J, Clendaniel A, Egan A, Garnick MB, Mitchell J, Knowles C, Ault KA. Recombinant human interleukin eleven (NEUMEGA rhlL-11 growth factor) increases plasma von Willebrand factor and fibrinogen concentrations in normal human subjects. Blood 1994; 84 (Suppl. 1): 276a (Abstr.).
68. Kawashima I, Ohsumi J, Mita-Honjo K, Shimoda-Takano K, Ishikawa H, Sakakibara S, Miyadai K, Takiguchi Y. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. Fed Eur Biochem Soc Lett 1991; 283: 199-202.
69. Ohsumi J, Miyadai K, Kawashima I, Ishikawa-Ohsumi H, Sakakibara S, Mita-Honjo K, Takiguchi Y. Adipogenesis inhibitory factor: a novel inhibitory regulator of adipose conversion in bone marrow. Fed Eur Biochem Soc Lett 1991; 288: 13-16.
70. Fuhrer DK, Yang YC. Activation of Src-family protein tyrosine kinases and phosphatidylinositol 3-kinase in 3T3-L1 mouse preadipocytes by. Exp Hematol 1996; 24: 195-203.
71. 3-induced osteoclast development. J Bone Min Res 1993; 7 (Suppl. 1): S110 (Abstr.).
72. Morinaga Y, Fujita N, Ohishi K, Zhang YK, Tsuruo T. Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors. J Cell Physiol 1998; 175: 247-254.
73. Verhaeghe J, Van Herck E, Van Bree R, Bouillon R, Dequeker J, Keith JC Jr. Recombinant human interleukin-11 does not modify biochemical parameters of bone remodeling and bone mineral density in adult ovariectomized rats. J Interfer Cytok Res 1998; 18: 49-53.
74. Taki H, Sugiyama E, Mino T, Kuroda A, Kobayashi M. Differential inhibitory effects of indomethacin, dexamethasone, and interferon-gamma (IFN-γ) on IL-11 production by rheumatoid synovial cells. Clin Exp Immunol 1998; 112: 133-138.
75. Hermann JA, Hall MA, Maini RN, Feldmann M, Brennan FM. Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1388-1397.
76. Trepicchio WL, Bozza M, Pedneault G, Dorner AJ. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996; 157: 3627-3634.
77. Redlich CA, Gao X, Rockwell S, Kelley M, Elias JA. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 1996; 157: 1705-1710.
78. Leng SX, Elias JA. Interleukin-11 inhibits macrophage interleukin-12 production. J Immunol 1997; 159: 2161-2168.
79. Du XX, Neben T, Goldman S, Williams DA. Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 1993; 81: 27-34.
80. Bozza M, Kyvelos D, Trepicchio WL, Collins M, Klempner MS, Dorner AJ. Recombinant human interleukin-11 does not affect functions of purified human neutrophils in vitro. J Interf Cytok Res 1998; 18: 889-895.
81. Neben S, Donaldson D, Fitz L, Calvetti J, Neben T, Turner K, Hirayama F, Ogawa M. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development. Exp Hematol 1996; 24: 783-789.
82. Anderson KC, Morimoto C, Paul SR, Chauhan D, Williams D, Cochran M, Barut BA. Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood 1992; 80: 2797-2804.
83. Keith JC Jr, Albert L, Sonis ST, Pfeiffer CJ, Schaub RG. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells (Dayt) 1994; 12 (Suppl. 1): 79-90.
84. Peterson RL, Wang L, Albert L, Keith JC Jr, Doner AJ. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest 1998; 78: 1503-1512.
85. Albert LM, Ferranti TJ, Erickson JE, Donnelly LH, Schaub RG, Keith JC Jr. Dose response and schedule studies of recombinant human interleukin-11 in acetic acid-induced colonic injury in rats. Gastroenterology 1995; 108 (Suppl. 4): A768 (Abstr.).
86. Qiu BS, Pfeiffer CJ, Keith JC Jr. Protection by recombinant human interleukin-11 against experimental TNBS-induced colitis in rats. Dig Dis Sci 1996; 41: 1625-1630.
87. Pfeiffer CJ, Sato S, Qiu BS, Keith JC Jr, Ta SE. Cellular pathology of experimental colitis induced by trinitrobenzenesulphonic acid (TNBS): protective effects of. Inflammopharmacology 1997; 5: 363-381.
88. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 1998; 101: 1970-1982.
89. Hill GR, Cooke KR, Teshmia T, Crawford JM, Keith JC Jr, Brinson YS, Bungard D, Ferrara JLM. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J Clin Invest 1998; 102: 115-123.
90. Barton BE, Shortall J, Jackson JV. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun 1996; 64: 714-718.
91. Misra BR, Ferranti TJ, Keith JC Jr, Donnelly LH, Erickson JE, Schaub RG. Recombinant human interleukin-11 prevents hypotension in LPS-treated anesthetized rabbits. J Endotox Res 1996; 3: 297-305.
92. Opal SM, Jhung JW, Keith JC, Palardy JE, Parejo NA, Young LD, Bhattacharjee A. Recombinant human interleukin-11 in experimental pseudomonas aeruginosa sepsis in immunocompromised animals. J Infect Dis 1998; 178: 1205-1208.
93. Takagi A, Yabe Y, Oka Y, Sawai K, Takakura Y, Hashida M. Renal disposition of recombinant human interleukin-11 in the isolated perfused rat kidney. Pharm Res 1997; 14: 86-90.
94. Aoyama K, Uchida T, Takanuki F, Usui T, Watanabe T, Higuchi S, Toyoki T, Mizoguchi H. Pharmacokinetics of recombinant human interleukin-11 (rhlL-11) in healthy male subjects. Br J Clin Pharmacol 1997; 43: 571-578.
95. Hutabarat R, Dykstra K, Patterson F, Sica D, Schwertschlag U. Pharmacokinetic study of rhlL-11 in subjects with renal failure and normal volunteers. Pharm Res 1997; 14: S606.
96. Dykstra K, Rogge H, Stone A, Loewy J, Schwertschlag U. Effect of diuretic treatment on rhlL-11-induced salt and water retention. Blood 1996; 88: 346a (Abstr.).
97. Ault KA, Mitchell J, Knowles C, Clendaniel A, Egan A, Loewy J, Garnick MB, Kaye JA. Recombinant human interleukin eleven (Neumega rhlL-11 growth factor) increases plasma volume and decreases urine sodium excretion in normal human subjects. Blood 1994; 84: (Suppl. 1): 276a (Abstr.).
98. Sands B, Bank S, Sninsky C, Robinson M, Katz S, Singleton J, Miner P, Safdi M, Galandiuk S, Hanauer S, Varilek G, Buchman A, Rogers V, Salzberg B, Cai B, Rogge H, Schwertschlag U. Safety and activity evaluation of rhlL-11 in subjects with active Crohn's disease. Gastroenterology 1999; 117: 1-8.